TR201007250A2 - Formulation containing cellobiose. - Google Patents

Formulation containing cellobiose.

Info

Publication number
TR201007250A2
TR201007250A2 TR2010/07250A TR201007250A TR201007250A2 TR 201007250 A2 TR201007250 A2 TR 201007250A2 TR 2010/07250 A TR2010/07250 A TR 2010/07250A TR 201007250 A TR201007250 A TR 201007250A TR 201007250 A2 TR201007250 A2 TR 201007250A2
Authority
TR
Turkey
Prior art keywords
formulation containing
containing cellobiose
cellobiose
copd
asthma
Prior art date
Application number
TR2010/07250A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/07250A priority Critical patent/TR201007250A2/en
Priority to PCT/TR2011/000198 priority patent/WO2012030308A2/en
Priority to EP11776267.4A priority patent/EP2611431A2/en
Publication of TR201007250A2 publication Critical patent/TR201007250A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Abstract

Mevcut buluş; astım ve KOAH gibi solunum yolları hastalıklarında kullanılmak üzere geliştirilmiş, bir taşıyıcı ve bir veya birden fazla etken madde içeren bir farmasötik kompozisyon ile ilgilidir.The present invention; It relates to a pharmaceutical composition for use in respiratory tract diseases such as asthma and COPD, comprising a carrier and one or more active ingredients.

TR2010/07250A 2010-09-01 2010-09-01 Formulation containing cellobiose. TR201007250A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2010/07250A TR201007250A2 (en) 2010-09-01 2010-09-01 Formulation containing cellobiose.
PCT/TR2011/000198 WO2012030308A2 (en) 2010-09-01 2011-08-24 Formulation comprising cellobiose
EP11776267.4A EP2611431A2 (en) 2010-09-01 2011-08-24 Formulation comprising cellobiose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/07250A TR201007250A2 (en) 2010-09-01 2010-09-01 Formulation containing cellobiose.

Publications (1)

Publication Number Publication Date
TR201007250A2 true TR201007250A2 (en) 2012-03-21

Family

ID=44883366

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/07250A TR201007250A2 (en) 2010-09-01 2010-09-01 Formulation containing cellobiose.

Country Status (3)

Country Link
EP (1) EP2611431A2 (en)
TR (1) TR201007250A2 (en)
WO (1) WO2012030308A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014007771A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising muscarinic receptor antagonist
WO2014007766A1 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhalers comprising a carrier other than lactose
WO2016116627A1 (en) 2015-01-22 2016-07-28 Pfeifer & Langen GmbH & Co. KG Cellobiose in compositions for consumption or ingestion
IT201900008340A1 (en) * 2019-06-07 2020-12-07 Genetic S P A MONTELUKAST SALTS AND THEIR PHARMACEUTICAL COMPOSITIONS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1204826B (en) 1986-03-04 1989-03-10 Chiesi Farma Spa INHALATION PHARMACEUTICAL COMPOSITIONS
GB9001635D0 (en) 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
GB0012261D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
US6482429B1 (en) * 2001-06-20 2002-11-19 Boehringer Ingelheim Pharmaceuticals, Inc. Stable powder inhalation dosage formulation
GB0208609D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Compositions
GB0312148D0 (en) * 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
GB0315889D0 (en) * 2003-07-08 2003-08-13 Aventis Pharma Ltd Stable pharmaceutical products
EP1643974A1 (en) * 2003-07-11 2006-04-12 Glaxo Group Limited Inhalable pharmaceutical formulations comprising a sugar ester

Also Published As

Publication number Publication date
WO2012030308A2 (en) 2012-03-08
EP2611431A2 (en) 2013-07-10
WO2012030308A3 (en) 2012-08-09

Similar Documents

Publication Publication Date Title
PH12014502778A1 (en) Antibody formulation
MY162146A (en) Pharmaceutical composition
GB201106750D0 (en) Novel compounds
EA201390145A1 (en) CONJUGATES, PARTICLES, COMPOSITIONS AND RELATED METHODS
WO2013122932A3 (en) Topical use of a skin-commensal prebiotic agent and compositions containing the same
BR112015012547A2 (en) prostacyclin compositions and methods for their use
MX348823B (en) Stable formulations of linaclotide.
EA201390049A1 (en) DRY POWDER PREPARATION CONTAINING PHOSPHODESTERASE INHIBITOR
TR200806298A2 (en) Pharmaceutical formulation
EA201590805A1 (en) COMPOSITION WITH IMMEDIATE AND PROLONGED DELIVERY
EA201591830A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING EVEROLIMUS
TN2012000488A1 (en) Pharmaceutical compositions comprising hydromorphone and naloxone
TR201008226A2 (en) An inhalation device containing capsules.
TR201903918T4 (en) Compositions containing a dispersing agent and their preparation.
TR201009167A2 (en) Pharmaceutical granules containing cephalosporin.
EA201171414A1 (en) IAP FAMILY INHIBITORS
TR201007250A2 (en) Formulation containing cellobiose.
TR200909785A1 (en) Pharmaceutical compositions containing cefdinir as the active agent.
WO2012093973A3 (en) Compositions in the form of tablets comprising acarbose
BR112012016736A2 (en) composition, pharmaceutical formulation and use of composition "
TR201005327A2 (en) Synergistic pharmaceutical formulations.
TR201109158A2 (en) Easily soluble pharmaceutical composition containing eplerenone.
TR201007251A2 (en) Calcium channel blocker formulation.
BR112013010061A2 (en) "pharmaceutical composition, composition and use"
TR201009165A2 (en) Tablets containing cefdinir